FLAREX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Flarex, and what generic alternatives are available?
Flarex is a drug marketed by Harrow Eye and is included in one NDA.
The generic ingredient in FLAREX is fluorometholone acetate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fluorometholone acetate profile page.
Summary for FLAREX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Patent Applications: | 2,211 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FLAREX |
What excipients (inactive ingredients) are in FLAREX? | FLAREX excipients list |
DailyMed Link: | FLAREX at DailyMed |
Pharmacology for FLAREX
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for FLAREX
US Patents and Regulatory Information for FLAREX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | FLAREX | fluorometholone acetate | SUSPENSION/DROPS;OPHTHALMIC | 019079-001 | Feb 11, 1986 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |